Furthermore, several cancer cell lines and tumors have been reported to express TFPIα [23,24], and enhanced levels of both TFPIα and TFPI-factor Xa (FXa) complexes have been detected in plasma of patients with solid tumors [25,26], supporting that TFPI may be involved in malignant disease mechanisms. The gene discussed is F10; the disease is cancer.